Literature DB >> 22422384

Consideration of optimal isodose surface selection for target coverage in micro-multileaf collimator-based stereotactic radiotherapy for large cystic brain metastases: comparison of 90%, 80% and 70% isodose surface-based planning.

K Ohtakara1, S Hayashi, H Tanaka, H Hoshi.   

Abstract

OBJECTIVE: This study aims to compare dynamic conformal arc (DCA) plans based on different-percentage isodose surfaces (IDSs), normalised to 100% at the isocentre, for target coverage (TC; dose prescription) in stereotactic radiotherapy for large cystic brain metastases.
METHODS: The DCA plans were generated for 15 targets (5 spherical models and 10 metastatic brain lesions) based on 90%, 80% and 70% IDSs for dose prescription to attain ≥99% TC values using the Novalis Tx platform. These plans were optimised mainly by leaf margin and/or collimator angle adjustment, while similar arc arrangements were used.
RESULTS: TC values were equivalent among the three plans. Conformity index values were similar between the 80% and 70% plans, while they were worse in the 90% plans. Mean doses (D(mean)) of the interior 3 mm rind structure were highest in the 70% plans, followed by the 80% plans and lowest in the 90% plans. D(mean) of the exterior 3 mm rind structure and the ratio of 50%/100% isodose volumes (Paddick's gradient index values) were highest in the 90% plans, followed by 80% and lowest in the 70% plans.
CONCLUSIONS: These results suggest that the 70% IDS plans might be beneficial for both tumour control and reducing toxicity to surrounding normal tissue if appropriate dose conformity and precise treatment set-up are ensured. The 90% IDS plans are unfavourable in view of inferior dose gradient outside the target and should be limited to cases in which the target dose homogeneity is given the highest priority.

Entities:  

Mesh:

Year:  2012        PMID: 22422384      PMCID: PMC3487079          DOI: 10.1259/bjr/21015703

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  27 in total

1.  Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.

Authors:  Antje Ernst-Stecken; Oliver Ganslandt; Ulrike Lambrecht; Rolf Sauer; Gerhard Grabenbauer
Journal:  Radiother Oncol       Date:  2006-09-15       Impact factor: 6.280

2.  Dosimetric characteristics of novalis Tx system with high definition multileaf collimator.

Authors:  Zheng Chang; Zhiheng Wang; Q Jackie Wu; Hui Yan; Jim Bowsher; Junan Zhang; Fang-Fang Yin
Journal:  Med Phys       Date:  2008-10       Impact factor: 4.071

3.  A simple dose gradient measurement tool to complement the conformity index.

Authors:  Ian Paddick; Bodo Lippitz
Journal:  J Neurosurg       Date:  2006-12       Impact factor: 5.115

4.  Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimator.

Authors:  Lisa J Hazard; Brian Wang; Thomas B Skidmore; Shyh-Shi Chern; Bill J Salter; Randy L Jensen; Dennis C Shrieve
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-06-17       Impact factor: 7.038

5.  Use of the BrainLAB ExacTrac X-Ray 6D system in image-guided radiotherapy.

Authors:  Jian-Yue Jin; Fang-Fang Yin; Stephen E Tenn; Paul M Medin; Timothy D Solberg
Journal:  Med Dosim       Date:  2008-04-01       Impact factor: 1.482

6.  Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases.

Authors:  Cesare Giubilei; Gianluca Ingrosso; Marco D'Andrea; Michaela Benassi; Riccardo Santoni
Journal:  J Neurooncol       Date:  2008-09-19       Impact factor: 4.130

7.  Beam shaping for SRT/SRS.

Authors:  D D Leavitt
Journal:  Med Dosim       Date:  1998       Impact factor: 1.482

8.  Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines.

Authors:  E Shaw; R Kline; M Gillin; L Souhami; A Hirschfeld; R Dinapoli; L Martin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-12-01       Impact factor: 7.038

9.  Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis.

Authors:  Richard Molenaar; Ruud Wiggenraad; Antoinette Verbeek-de Kanter; Rob Walchenbach; Charles Vecht
Journal:  Br J Neurosurg       Date:  2009-04       Impact factor: 1.596

10.  Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions.

Authors:  Q Jackie Wu; Zhiheng Wang; John P Kirkpatrick; Zheng Chang; Jeffrey J Meyer; Mei Lu; Calvin Huntzinger; Fang-Fang Yin
Journal:  Radiat Oncol       Date:  2009-01-21       Impact factor: 3.481

View more
  12 in total

1.  Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.

Authors:  Kazuhiro Ohtakara; Shinya Hayashi; Noriyuki Nakayama; Naoyuki Ohe; Hirohito Yano; Toru Iwama; Hiroaki Hoshi
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

2.  A new variable for SRS plan quality evaluation based on normal tissue sparing: the effect of prescription isodose levels.

Authors:  Q Zhang; D Zheng; Y Lei; B Morgan; J Driewer; M Zhang; S Li; S Zhou; W Zhen; R Thompson; A Wahl; C Lin; C Enke
Journal:  Br J Radiol       Date:  2014-09-16       Impact factor: 3.039

3.  Cerebral cyst formation following stereotactic ablative irradiation for non-nasopharyngeal head and neck malignancies: imaging findings and relevant dosimetric parameters.

Authors:  K Ohtakara; H Hoshi
Journal:  Br J Radiol       Date:  2014-02-26       Impact factor: 3.039

4.  Modifying the planning target volume to optimize the dose distribution in dynamic conformal arc therapy for large metastatic brain tumors.

Authors:  Kengo Ogura; Yasuhiro Kosaka; Toshiyuki Imagumbai; Kazuhito Ueki; Ryo Narukami; Takayuki Hattori; Masaki Kokubo
Journal:  Jpn J Radiol       Date:  2017-04-06       Impact factor: 2.374

5.  The Incidence and Its Associated Factors Relevant to Brain Radionecrosis That Requires Intervention Following Single or Fractionated Stereotactic Radiosurgery Using Vero4DRT for Brain Metastases.

Authors:  Takehiro Yamada; Kazuhiro Ohtakara; Takeshi Kamomae; Junji Itoh; Hideki Shimada; Shunichi Ishihara; Shinji Naganawa
Journal:  Cureus       Date:  2022-06-13

6.  The effect of setup uncertainty on optimal dosimetric margin in LINAC-based stereotactic radiosurgery with dynamic conformal arc technique.

Authors:  Xiaoyu Duan; William Giles; John P Kirkpatrick; Fang-Fang Yin
Journal:  J Radiosurg SBRT       Date:  2019

7.  Prescription to 50-75% isodose line may be optimum for linear accelerator based radiosurgery of cranial lesions.

Authors:  Bo Zhao; Jian-Yue Jin; Ning Wen; Yimei Huang; M Salim Siddiqui; Indrin J Chetty; Samuel Ryu
Journal:  J Radiosurg SBRT       Date:  2014

8.  Operation and calibration of the novel PTW 1600SRS detector for the verification of single isocenter stereotactic radiosurgery treatments of multiple small brain metastases.

Authors:  Esther Decabooter; Ans Cc Swinnen; Michel C Öllers; Fabian Göpfert; Frank Verhaegen
Journal:  Br J Radiol       Date:  2021-06-11       Impact factor: 3.629

9.  The impact of isocentric shifts on delivery accuracy during the irradiation of small cerebral targets-Quantification and possible corrections.

Authors:  Linda J Wack; Florian Exner; Sonja Wegener; Otto A Sauer
Journal:  J Appl Clin Med Phys       Date:  2020-03-20       Impact factor: 2.102

Review 10.  Proton versus Photon Radiotherapy for Pediatric Central Nervous System Malignancies: A Systematic Review and Meta-Analysis of Dosimetric Comparison Studies.

Authors:  Roberta Carbonara; Alessia Di Rito; Angela Monti; Giuseppe Rubini; Angela Sardaro
Journal:  J Oncol       Date:  2019-11-27       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.